FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and can be used for growth inhibition of methicillin-resistant Staphylococcus aureus strain. Method provides for radiation treatment of bacterial cell suspension of methicillin-resistant Staphylococcus aureus strain with ruby light (λ -660 nm). Power density is 100 mW/cm2, radiation time is 10, 15 or 30 minutes in a continuous mode. Radiant exposure is 60, 90 and 180 J/cm2 respectively.
EFFECT: invention simplifies the method for staphylococci growth inhibition.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-PBP2A PROTEIN MONOCLONAL ANTIBODIES AND HOMOLOGOUS SEQUENCES FOR TREATING BACTERIAL INFECTION AND IMMUNODIAGNOSIS OF Firmicutes BACTERIA | 2010 |
|
RU2575070C2 |
| METHOD FOR STAPHYLOCOCCUS AUREUS GENOTYPING | 2012 |
|
RU2526497C2 |
| METHOD FOR DETECTING METHICILLIN RESISTANCE GENES mecA AND mecC IN STAPHYLOCOCCI | 2021 |
|
RU2755690C1 |
| DRUG FOR TREATMENT OF DISEASES CAUSED BY BACTERIA | 2020 |
|
RU2754610C1 |
| METHOD FOR OVERCOMING GENTAMYCIN RESISTANCE IN METHICILLIN-RESISTANT S. AUREUS STRAINS | 2013 |
|
RU2553601C2 |
| STRAIN OF STAPHYLOCOCCUS AUREUS CHARACTERIZED BY RESISTANCE TO DAPTOMYCIN AND USED AS A CONTROL TEST CULTURE TO DETERMINE ANTIBIOTIC SENSITIVITY | 2022 |
|
RU2809847C1 |
| CIPROFLOXACIN DERIVATIVE WITH ANTIBACTERIAL ACTIVITY AGAINST ANTIBIOTIC-RESISTANT STRAINS OF MICROORGANISMS | 2021 |
|
RU2757741C1 |
| STRAIN OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) CHARACTERIZED BY RESISTANCE TO CEFTAROLINE AND USED AS A CONTROL TEST CULTURE TO DETERMINE SENSITIVITY TO BETA-LACTAM ANTIBIOTICS (VARIANTS) | 2022 |
|
RU2798788C1 |
| MIXED METAL COMPLEXES BASED ON 5-(4-METHYLPHENYL)-2,2'-BIPYRIDINE AND (TETRAFLUOR) SALICYLIC ACIDS, HAVING ANTIBACTERIAL AND FUNGISTATIC ACTIVITY | 2020 |
|
RU2737435C1 |
| STAPHYLOCOCCUS AUREUS STRAINS CHARACTERIZED BY RESISTANCE TO VANCOMYCIN AND USED AS CONTROL TEST CULTURES FOR DETERMINING SENSITIVITY TO GLYCOPEPTIDE ANTIBIOTICS | 2022 |
|
RU2802896C1 |
